Eurofins Clinical Diagnostics DACH old
Eurofins Clinical Diagnostics DACH operates seven accredited clinical laboratories across Germany providing laboratory medicine, human genetics, microbiology, molecular diagnostics, prenatal testing, and hospital hygiene to physicians and hospitals. It is part of Eurofins Scientific SE.
- Company typePrivate
- Founded-
- HeadquartersHamburg, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Eurofins Clinical Diagnostics DACH old does
Eurofins Clinical Diagnostics DACH is the clinical diagnostics arm of Eurofins Scientific SE in Germany, operating a coordinated network of seven accredited laboratories across the country under the sub-brands Eurofins GeLaMed, Eurofins Humangenetik, Eurofins Pränatal-Medizin, and Eurofins LifeCodexx. The business delivers routine and specialty diagnostic services — laboratory medicine, microbiology, molecular diagnostics, human genetics, prenatal medicine, and hospital hygiene — to referring physicians, medical practices, hospitals, and clinics. Origins trace back to the 1902 Hygiene-Institut des Ruhrgebiets (founded on Robert Koch's recommendation), with the lab-medicine division joining Eurofins in July 2017; the network now employs approximately 650 highly qualified staff and processes roughly 12,000 samples daily at GeLaMed locations alone across more than 2,000 different examinations.
The portfolio combines classical clinical chemistry, hematology, immunology, microbiology, and serology with advanced molecular and genetic capabilities: PCR-based infection diagnostics, next-generation sequencing (NGS) panels, clinical and whole exome sequencing, Array-CGH, FISH, and the proprietary PraenaTest® non-invasive prenatal test (NIPT) — the first NIPT in Europe and Germany's first, which became a statutory health insurance (GKV) benefit in July 2022 and is offered alongside extensions PraenaRhD and PraenaGenom. Diagnostic hardware includes Abbott Alinity m fully automated molecular analyzers and two computer-aided laboratory lines. Quality is anchored in DIN EN ISO 15189 accreditation across all sites and DIN EN ISO/IEC 17025 for the Gelsenkirchen hospital hygiene department, with compliance to RiliBÄK and participation in ring trials.
The business model is B2B enterprise field sales: an outside sales force (Außendienst) and a digital Order Entry platform / LabApp drive test orders from medical professionals, with sample transport logistics linking practices and hospitals to the appropriate laboratory. Revenue is generated primarily as transaction fees billed to statutory (GKV) and private health insurers via the German EBM/GOÄ reimbursement framework, complemented by self-pay Individual Health Services (IGeL) such as the microRNA 371 testicular cancer test, preeclampsia screening, and extended PraenaGenom panels. Distribution is exclusively direct — no third-party resellers — across the seven-site German laboratory network, with the DACH brand positioning pointing to potential future expansion into Austria and Switzerland.
Eurofins Clinical Diagnostics DACH old firmographics
Firmographics- Name
- Eurofins Clinical Diagnostics DACH old
- Legal name
- Eurofins Clinical Diagnostics DACH
- Website
- https://eurofins-clinical.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Eurofins Clinical Diagnostics DACH operates seven accredited clinical laboratories across Germany providing laboratory medicine, human genetics, microbiology, molecular diagnostics, prenatal testing, and hospital hygiene to physicians and hospitals. It is part of Eurofins Scientific SE.
- Ownership category
- akta.pro rank
Eurofins Clinical Diagnostics DACH old industry classification
Industry- Product category
- Clinical Laboratory Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Reference & Esoteric Testing Laboratories (HLAFAMAJ)
- akta.pro secondary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
Keywords
Where Eurofins Clinical Diagnostics DACH old is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices8 records
Markets served
Eurofins Clinical Diagnostics DACH old business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Clinical Diagnostic Laboratory Services: B2B laboratory testing services billed to statutory (GKV) and private health insurers, hospitals, and referring physicians. Revenue generated through German health insurance billing codes (EBM) and private payor agreements. Core revenue stream across lab medicine, microbiology, molecular diagnostics, and genetics.
- Non-Invasive Prenatal Testing (NIPT / PraenaTest®): NIPT testing for trisomies, offered as a statutory health insurance benefit (since July 2022) and as an individual health service (IGeL/self-pay) for additional genomic panels (PraenaGenom).
- IGeL (Individual Health Services): Self-pay diagnostic services not covered by statutory insurance, including allergy diagnostics, microRNA 371 test for testicular cancer, and preeclampsia testing.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
Eurofins Clinical Diagnostics DACH old product offering
Product offeringCore offering
Eurofins Clinical Diagnostics DACH operates a network of seven clinical diagnostic laboratories across Germany providing laboratory medicine, human genetics, microbiology, molecular diagnostics, and hospital hygiene services to referring physicians and hospitals. The portfolio spans clinical chemistry, hematology, immunology, microbiology, oncology, serology, prenatal diagnostics (including the proprietary PraenaTest® NIPT), genetic sequencing, and hygiene inspections, billed primarily through the German statutory and private health insurance system.
Product overview
Eurofins Clinical Diagnostics DACH operates as a unified clinical diagnostic network offering laboratory medicine, human genetics, prenatal medicine, microbiology, molecular diagnostics, and hospital hygiene services. The portfolio includes core diagnostic brands (Eurofins Clinical Diagnostics DACH, Eurofins Humangenetik, Eurofins Pränatal-Medizin, Eurofins GeLaMed) and specific products like the PraenaTest® NIPT family (PraenaTest®, PraenaRhD, PraenaGenom). Seven laboratories across Germany are coordinated through the network, supported by Order Entry and LabApp systems for electronic test ordering and results delivery.
Differentiator
Problem solved
Functional benefit
Brands
- PraenaTest®: Non-invasive prenatal testing (NIPT) product for trisomy detection (13, 18, 21) - the first NIPT in Europe
- PraenaRhD
- PraenaGenom
Quantifiable outcome
- 12,000 samples processed daily across GeLaMed laboratories
- +3 more outcomes
Companies that use Eurofins Clinical Diagnostics DACH old
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Eurofins Clinical Diagnostics DACH old technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Eurofins Clinical Diagnostics DACH old partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ärzte ohne Grenzen Deutschland (Médecins Sans Frontières)coreEurofins Clinical Diagnostics DACH is an official cooperation partner of Ärzte ohne Grenzen Deutschland (Médecins Sans Frontières). The partnership focuses on supporting women's health projects. Additionally, Eurofins runs the 'Sie Senden Wir Spenden' campaign, donating 1 Euro for every Praena blood sample returned via Deutsche Post to support MSF projects.
Scale indicators9 records
Recent moves10 records
Expansion highlights7 records
Eurofins Clinical Diagnostics DACH old competitors and assessment
Company assessmentEmerging players
- Centogene: Germany-based rare disease and genetic diagnostics company offering exome/genome sequencing, biomarker testing, and prenatal screening. Comparable in the human genetics/prenatal testing portfolio, with overlap in NIPT-adjacent offerings.
- CeGaT: German provider of genetic diagnostics (NGS panels, exome, whole genome) and NIPT services. Comparable in human genetics and NIPT product lines, particularly overlapping with PraenaTest and exome offerings, though more specialized.
Broad incumbents
- University Hospital Laboratories (e.g., UKB Bonn, Charité Berlin): Public/university hospital laboratories providing advanced clinical and genetic diagnostics with strong specialty and research capabilities. Comparable as established providers of reference/esoteric and genetic testing that compete for complex cases.
- Sonic Healthcare: Global medical diagnostics operator with German operations (Dr. Limbach, LADR-adjacent acquisitions). Comparable as a broader incumbent operating multi-site clinical labs in Germany with similar services.
Others
- Helios Hospital Group (Fresenius): Largest private hospital operator in Germany running in-house laboratories serving its hospital network. Comparable as a customer/competitor for hospital hygiene and clinical lab services, though the laboratory is captive rather than commercial.
Direct peers
- MVZ Labor Dr. Limbach (part of Sonic Healthcare): Major German medical laboratory network within Sonic Healthcare providing clinical diagnostics and specialty testing to physicians and hospitals. Comparable as a multi-site, full-service clinical lab competitor in the German market.
- Labor Berlin: Hospital-affiliated medical laboratory in Berlin providing clinical diagnostics, microbiology, and genetics to hospitals and referring physicians. Comparable in service breadth and German hospital/physician customer base.
- Synlab: Europe's largest medical diagnostics services provider with extensive German laboratory operations offering routine clinical lab, specialty, and genetic testing. Directly comparable in product scope (clinical chemistry, microbiology, genetics, hospital services) and customer base (physicians and hospitals), making it the most direct competitor.
- LADR Laborverbund Dr. Kramer & Kollegen: German network of medical laboratories serving physicians and hospitals with clinical chemistry, microbiology, immunology, and human genetics diagnostics. Closely comparable in scope and DACH-region physician-focused GTM.
- amedes Holding: European laboratory group with significant German operations offering clinical diagnostics, human genetics, and gynecology/prenatal testing. Directly comparable given shared focus on genetics and prenatal services in Germany.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks4 records
Key highlights6 records
Customer concentration
Eurofins Clinical Diagnostics DACH old social profiles
Digital presenceEurofins Clinical Diagnostics DACH old compliance and trust
Trust signalCompliance4 records
Eurofins Clinical Diagnostics DACH old financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eurofins Clinical Diagnostics DACH old leadership team
Management profileNumber of profiles
Eurofins Clinical Diagnostics DACH old subsidiaries and ownership
Company hierarchySubsidiaries4 records
Eurofins Clinical Diagnostics DACH old funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eurofins Clinical Diagnostics DACH old M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eurofins Clinical Diagnostics DACH old
What does Eurofins Clinical Diagnostics DACH old do?
Eurofins Clinical Diagnostics DACH operates a network of seven clinical diagnostic laboratories across Germany providing laboratory medicine, human genetics, microbiology, molecular diagnostics, and hospital hygiene services to referring physicians and hospitals. The portfolio spans clinical chemistry, hematology, immunology, microbiology, oncology, serology, prenatal diagnostics (including the proprietary PraenaTest® NIPT), genetic sequencing, and hygiene inspections, billed primarily through the German statutory and private health insurance system.
Is Eurofins Clinical Diagnostics DACH old a public or private company?
Eurofins Clinical Diagnostics DACH old is a private company. It is classified as corporate owned and is currently operating.
When was Eurofins Clinical Diagnostics DACH old founded?
Eurofins Clinical Diagnostics DACH old was founded in -1. It employs 1 to 10 people.
Where is Eurofins Clinical Diagnostics DACH old based?
Eurofins Clinical Diagnostics DACH old is headquartered in Hamburg, Germany, in the Europe region.
How does Eurofins Clinical Diagnostics DACH old make money?
Three revenue lines are on record. Clinical Diagnostic Laboratory Services are the primary driver. The others are non-Invasive Prenatal Testing (NIPT / PraenaTest®) and IGeL (Individual Health Services).
Who are Eurofins Clinical Diagnostics DACH old's main competitors?
Emerging players on record are Centogene and CeGaT. Broad incumbents are University Hospital Laboratories (e.g., UKB Bonn, Charité Berlin) and Sonic Healthcare. Helios Hospital Group (Fresenius) is listed as an others. Direct peers are MVZ Labor Dr. Limbach (part of Sonic Healthcare), Labor Berlin, Synlab, LADR Laborverbund Dr. Kramer & Kollegen and amedes Holding.
Does Eurofins Clinical Diagnostics DACH old have an API?
No public API is recorded for Eurofins Clinical Diagnostics DACH old.
What industry is Eurofins Clinical Diagnostics DACH old in?
Eurofins Clinical Diagnostics DACH old's product category is Clinical Laboratory Diagnostics. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.